| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 317,730 | 284,542 | 271,493 | 334,610 | | Cost of Revenue | 218,991 | 192,718 | 176,088 | 201,659 | | | Gross Profit | 98,739 | 91,824 | 95,405 | 132,951 | | | Operating Expenses | | Research Development | 51,460 | 52,186 | 52,557 | 61,859 | | Selling General and Administrative | 58,252 | 50,882 | 54,918 | 77,881 | | Non Recurring | 3,934 | 6,361 | 8,452 | 11,449 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (14,743) | (17,605) | (20,522) | (18,238) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,703 | (2,780) | (1,759) | (62) | | Earnings Before Interest And Taxes | (20,600) | (20,385) | (22,281) | (18,300) | | Interest Expense | (3,545) | 1,759 | 1,786 | 2,528 | | Income Before Tax | (17,055) | (22,144) | (24,067) | (20,828) | | Income Tax Expense | 395 | (9,737) | (27,693) | 3,524 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (17,450) | (12,407) | 3,626 | (24,352) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (17,450) | (12,407) | 3,626 | (24,352) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($17,450) | ($12,407) | $3,626 | ($24,352) |
|
0.07% Nasdaq 
Income Statement
